查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
掌腱膜攣縮症市場，按類型、疾病類型、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419084

掌腱膜攣縮症市場，按類型、疾病類型、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Dupuytren's Disease Market, By Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年掌腱膜攣縮症市場規模為 41.310 億美元，2023 年至 2030 年複合CAGR為 4.44%。

掌腱膜攣縮症市場-市場動態

醫學研究和技術的不斷發展以及疾病的流行推動了市場需求

這種疾病發生率的上升推動了市場的顯著擴張。最近發表在《手外科雜誌》上的一項研究表明，越來越多的患者需要治療選擇，並顯示診斷病例顯著增加。為了滿足對高效管理技術的需求，製藥公司和醫療器材製造商擴大了研發支出。此外，根據2021年在美國進行的人口調查，高達7%的人出現臨床症狀，其中超過三分之一的人受到掌腱膜攣縮症的影響。

此外，醫學技術和科學發展的不斷成長也促進了市場的成長。隨著產業的發展，利害關係人有潛力滿足患者不斷變化的需求並改善疾病管理結果。 《手外科雜誌》強調需要更多的非手術方法來治療掌腱膜攣縮症，並鼓勵手外科醫師就新的治療方法和技術進行持續對話。

掌腱膜攣縮症市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 4.44% 左右的CAGR成長
  • 根據類型細分，由於高度重視開發治療方案，治療細分市場預計將在 2022 年顯示最大的市場佔有率。
  • 從疾病類型細分來看，2022年疾病類型細分為主導細分，以掌筋膜為主要特徵。
  • 根據最終用戶細分，醫院細分市場是 2022 年的領先細分市場，主要是由於醫療保健設施的不斷發展。
  • 從地區來看，由於掌腱膜攣縮症的高發生率，北美是 2022 年的主要收入來源。

掌腱膜攣縮症市場-細分分析：

全球掌腱膜攣縮症市場根據類型、疾病類型、最終用戶和地區進行細分。

市場根據類型分為兩類：診斷和治療。治療領域佔據市場主導地位。製藥公司致力於開發治療疾病的創新治療解決方案。

根據疾病類型，市場分為三類： I型、II型和III型。 II 類細分市場在市場中佔據主導地位，並可能在預測期內保持其主導地位。數位線纜損傷疾病的日益普及可能會促進市場成長。

根據最終用戶，市場分為四大類：醫院、診所、研究機構等。醫院領域在市場中佔據主導地位，並可能在預測期內保持其主導地位。醫院提供整體護理治療，預計將推動市場成長。

掌腱膜攣縮症市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

掌腱膜攣縮症市場-競爭格局：

由於患者數量的增加、治療的改善和意識的提高，市場正在顯著擴大。主要參與者可以透過提供專門的護理和有效的治療來利用這些機會。為了增加產業佔有率，市場參與者持續參與合併、收購和合作等策略活動。例如，2022 年 4 月，180 Life Sciences 和牛津大學宣佈公佈 Dupuytren 的 2b 期研究結果。

最近的發展：

2023 年 4 月，一家新成立的專業製藥公司 Ventoux Biosciences 致力於改變包括掌腱膜攣縮症在內的纖維化疾病的治療。

目錄

第1章：掌腱膜攣縮症市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的掌腱膜攣縮症市場片段
    • 依疾病類型分類的掌腱膜攣縮症市場片段
    • 最終用戶的掌腱膜攣縮症市場片段
    • 按國家/地區分類的掌腱膜攣縮症市場片段
    • 按地區分類的掌腱膜攣縮症市場片段
  • 競爭洞察

第 3 章：掌腱膜攣縮症主要市場趨勢

  • 掌腱膜攣縮症市場促進因素
    • 市場促進因素的影響分析
  • 掌腱膜攣縮症市場限制
    • 市場限制影響分析
  • 掌腱膜攣縮症市場機會
  • 掌腱膜攣縮症市場未來趨勢

第 4 章：掌腱膜攣縮症產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：掌腱膜攣縮症市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：掌腱膜攣縮症市場格局

  • 掌腱膜攣縮症市場佔有率分析，2022 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：掌腱膜攣縮症市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 診斷
    • 治療

第 8 章：掌腱膜攣縮症市場 - 依疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • Ⅰ型
    • II型
    • Ⅲ型

第 9 章：掌腱膜攣縮症市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 研究機構
    • 其他

第 10 章：掌腱膜攣縮症市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 掌腱膜攣縮症北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按疾病類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 掌腱膜攣縮症歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按疾病類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 掌腱膜攣縮症亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按疾病類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 掌腱膜攣縮症拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 掌腱膜攣縮症中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：關鍵供應商分析 - 掌腱膜攣縮症產業

  • 競爭儀表板
  • 公司簡介
    • BASF SE
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Endo International plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • Fresenius Kabi AG
    • GSK plc
    • AstraZeneca
    • Hikma Pharmaceuticals PLC
    • LEO Pharma A/S
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2149

REPORT HIGHLIGHT

Dupuytren's Disease Market size was valued at USD 4,131.00 Million in 2022, expanding at a CAGR of 4.44% from 2023 to 2030.

Dupuytren's disease causes Fascia, a layer of tissue beneath the skin, thickens abnormally in the palm of your hand near the base of your fingers. This enlarged region could turn into a thick band or hard lump.

Dupuytren's Disease Market- Market Dynamics

Increasing developments in medical research & technology and prevalence of disease to propel market demand

The rising incidence of the illness is fueling the market's notable expansion. A growing number of patients need treatment choices, as evidenced by a recent study that was published in the Journal of Hand Surgery and showed a noticeable increase in diagnosed cases. To address the demand for efficient management techniques, pharmaceutical businesses and makers of medical devices have expanded their spending in research and development. Furthermore, according to a population survey conducted in the United States in 2021, up to 7% of people have clinical symptoms, and over one-third of those people are impacted by Dupuytren's contractures.

Furthermore, the growing number of technological and scientific developments in medicine also contributing to market growth. Stakeholders have potential to address patients' changing requirements and improve illness management results as the industry grows. The Journal of Hand Surgery highlights the need for more nonsurgical methods to treat Dupuytren's disease and encourages continuous dialogue among hand surgeons about new treatments and techniques.

Dupuytren's Disease Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.44% over the forecast period (2023-2030)
  • Based on Type segmentation, treatment segment was predicted to show maximum market share in the year 2022, owing to high focus on developing treatment options.
  • Based on Disease Type segmentation, disease type II segment was the leading segment in 2022, mainly characterized palmer fascia.
  • Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing development healthcare facilities.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high prevalence of Dupuytren disease.

Dupuytren's Disease Market- Segmentation Analysis:

The Global Dupuytren's Disease Market is segmented on the basis of Type, Disease Type, End-User, and Region.

The market is divided into two categories based on Type: diagnosis and treatment. The treatment segment dominates the market. Pharmaceutical companies are focusing on developing innovative treatment solutions for treatment of disease.

The market is divided into three categories based on Disease Type: Type I, Type II, and Type III. The Type II segment dominates the market and is likely to maintain its dominance during the forecast period. The growing prevalence of disease with digital cords impairment are likely to boost market growth.

The market is divided into four categories based on End-User: hospitals, clinics, research institutes, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. Hospitals provide holistic care treatment care and is expected to boost the market growth.

Dupuytren's Disease Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Dupuytren's Disease Market- Competitive Landscape:

The market is expanding significantly because of rising patient numbers, improved treatment, and more awareness. Major players can take advantage of these opportunities by providing specialized care and efficient therapies. To increase their industry share, market players are constantly taking part in strategic activities including mergers, acquisitions, and partnerships. For example, in April 2022, 180 Life Sciences and the University of Oxford announced the publication of positive Phase 2b study results for Dupuytren's.

Recent Developments:

In April 2023, a newly launched specialty pharmaceutical company called Ventoux Biosciences, which is dedicated to transforming the management of fibrotic diseases, including Dupuytren's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DUPUYTREN'S DISEASE MARKET KEY PLAYERS

  • BASF SE
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Private Limited
  • Endo International plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • Fresenius Kabi AG
  • GSK plc
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • LEO Pharma A/S
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY TYPE

  • Diagnosis
  • Treatment

GLOBAL DUPUYTREN'S DISEASE MARKET, BY DISEASE TYPE

  • Type I
  • Type II
  • Type III

GLOBAL DUPUYTREN'S DISEASE MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

GLOBAL DUPUYTREN'S DISEASE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dupuytren's Disease Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dupuytren's Disease Market Snippet by Type
    • 2.1.2. Dupuytren's Disease Market Snippet by Disease Type
    • 2.1.3. Dupuytren's Disease Market Snippet by End-User
    • 2.1.4. Dupuytren's Disease Market Snippet by Country
    • 2.1.5. Dupuytren's Disease Market Snippet by Region
  • 2.2. Competitive Insights

3. Dupuytren's Disease Key Market Trends

  • 3.1. Dupuytren's Disease Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dupuytren's Disease Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dupuytren's Disease Market Opportunities
  • 3.4. Dupuytren's Disease Market Future Trends

4. Dupuytren's Disease Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dupuytren's Disease Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dupuytren's Disease Market Landscape

  • 6.1. Dupuytren's Disease Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dupuytren's Disease Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Diagnosis
    • 7.1.3. Treatment

8. Dupuytren's Disease Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Type I
    • 8.1.3. Type II
    • 8.1.4. Type III

9. Dupuytren's Disease Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Dupuytren's Disease Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dupuytren's Disease Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dupuytren's Disease Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dupuytren's Disease Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dupuytren's Disease Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dupuytren's Disease Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Dupuytren's Disease Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. BASF SE
    • 11.2.2. Bayer AG
    • 11.2.3. Novartis AG
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Nantong Jinghua Pharmaceutical Co., Ltd.
    • 11.2.6. Actiza Pharmaceutical Private Limited
    • 11.2.7. Endo International plc
    • 11.2.8. Bristol-Meyers Squibb Company
    • 11.2.9. Spear Pharmaceuticals
    • 11.2.10. Fresenius Kabi AG
    • 11.2.11. GSK plc
    • 11.2.12. AstraZeneca
    • 11.2.13. Hikma Pharmaceuticals PLC
    • 11.2.14. LEO Pharma A/S
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dupuytren's Disease Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Dupuytren's Disease Market, by Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Dupuytren's Disease Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Dupuytren's Disease Market, by End-User 2018-2030 (USD Million)
  • TABLE Dupuytren's Disease Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dupuytren's Disease Market, by Region 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dupuytren's Disease Market, by End-User, 2018-2030 (USD Million)